StemPrintER Demonstrates Prognostic Utility in TransATAC Cohort - GlobeNewswire
3/1/2022 12:00:00 AM4 yearsago
by Tiziana Life Sciences Plc
by Tiziana Life Sciences Plc
NEW YORK, March 01, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd.’s (Nasdaq: TLSA) former subsidiary, AccuStem Sciences, Inc. (OTC PINK: ACMSY)......
NEW YORK, March 01, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd.s (Nasdaq: TLSA) former subsidiary, AccuStem Sciences, Inc. (OTC PINK: ACMSY) (formerly AccuStem Sciences Ltd.), today announced… [+4210 chars]
full article...